Biomedcode’s human TNF transgenic arthritis model, (Tg197), contributes to the non-clinical assessment of adalimumab biosimilar GP2017 with originator Humira. Read More
Biomedcode’s human TNF transgenic arthritis model, (Tg197), contributes to the non-clinical assessment of etanercept biosimilar GP2015 with originator etanercept (Enbrel).
Published in Expert Opinion on Biological Therapy 2016 Vol. 16 , Iss. 10, 1185-1195.
Read More
Biomedcode coauthors a publication in the Journal of Proteome Research on the identification of a biomarker with translational value for the diagnosis and monitoring of rheumatoid arthritis disease and therapy.
Published in Journal of Proteome Research 2016 Dec 2;15(12):4579-4590. doi: 10.1021/acs.jproteome.6b00654.
Read More